Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

2.66
Delayed Data
As of Sep 22
 +0.20 / +8.13%
Today’s Change
2.20
Today|||52-Week Range
5.02
-24.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash31.7M42.5M42.5M66.2M
 
 
 
 
 
Short Term Investment Cash-739.0K10.7M36.0K23.7M
 
 
 
 
 
Cash & Short Term Investments202.5M189.2M166.5M153.6M
 
 
 
 
 
 
ReceivablesReceivables2.3M2.4M1.9M1.8M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.9M4.0M5.1M4.7M
 
 
 
 
 
Current Assets209.7M195.6M173.5M160.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--33.2M----
 
 
Depreciation---20.0M----
 
 
Intangible Assets29.0M172.5M172.2M172.0M
 
 
 
 
 
Other Assets30.9M174.6M174.2M174.0M
 
 
 
 
 
Total Assets251.9M383.4M360.0M346.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.0M1.7M2.7M2.0M
 
 
 
 
 
Accrued Expenses13.2M21.5M19.4M21.3M
 
 
 
 
 
Other Current Liabilities17.6M26.4M24.4M26.8M
 
 
 
 
 
Other Liabilities18.6M35.2M27.0M28.8M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities16.2M82.7M85.2M85.8M
 
 
 
 
 
Total Liabilities34.9M117.9M112.2M114.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity217.1M265.4M247.8M231.5M
 
 
 
 
 
Total Shareholder Equity217.1M265.4M247.8M231.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding101.2M120.5M124.2M127.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.